Bausch Health ehemals VALEANT PHARMA Allergan-Übernahme beflügelt (Seite 89)
eröffnet am 30.04.14 17:10:46 von
neuester Beitrag 10.04.24 21:16:45 von
neuester Beitrag 10.04.24 21:16:45 von
Beiträge: 4.274
ID: 1.193.944
ID: 1.193.944
Aufrufe heute: 8
Gesamt: 389.635
Gesamt: 389.635
Aktive User: 0
ISIN: CA0717341071 · WKN: A2JQ1X · Symbol: BVF
7,9960
EUR
+0,73 %
+0,0580 EUR
Letzter Kurs 09:30:22 Tradegate
Neuigkeiten
11.04.24 · Accesswire |
11.04.24 · Accesswire |
03.04.24 · Accesswire |
02.04.24 · Accesswire |
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
3,5800 | +922,86 | |
0,8800 | +95,56 | |
2.000,00 | +71,23 | |
29,10 | +21,25 | |
0,9650 | +14,88 |
Wertpapier | Kurs | Perf. % |
---|---|---|
9,7200 | -19,60 | |
1,5000 | -24,62 | |
14,510 | -32,32 | |
3,6400 | -38,62 | |
0,7000 | -61,85 |
Beitrag zu dieser Diskussion schreiben
Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)
https://www.streetinsider.com/dr/news.php?id=14595094&gfv=1Die Milestone Zahlungen von Xenon an BHC wurde abgekauft, also durch Einmalzahlung vorab beglichen. Damit ist BHC zur aktuellen Schuldenrückzahlung fähig.
Bausch Health Reduces Debt By Additional $107 Million, Eliminating All Remaining Mandatory Amortization For 2018
https://www.bauschhealth.com/news-room/news-releases/news-de…
https://www.bauschhealth.com/news-room/news-releases/news-de…
Norgine und sein Partner Salix geben die Markteinführung von PLENVU® in den USA bekannt
https://www.finanzen.net/nachricht/aktien/norgine-und-sein-p… Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies
http://crweworld.com/article/news-provided-by-pr-newswire/79…
NACDS Recognized LUMIFY as Best-in-Class in Healthcare and Over-the-Counter Category
LUMIFY™ Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winnerhttps://www.bauschhealth.com/news-room/news-releases/news-de…
https://www.tandfonline.com/action/doSearch?AllField=Methyln…
Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review
https://www.tandfonline.com/doi/full/10.1080/00325481.2016.1…
Overview and Treatment of Opioid-Induced Constipation
https://www.tandfonline.com/doi/abs/10.3810/pgm.2013.07.2651
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review
https://www.tandfonline.com/doi/full/10.1080/00325481.2016.1…
Overview and Treatment of Opioid-Induced Constipation
https://www.tandfonline.com/doi/abs/10.3810/pgm.2013.07.2651
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
Salix Pharmaceuticals To Present Clinical Data For The Treatment Of Opioid-Induced Constipation At 2018 PAINWeek Conference
https://markets.businessinsider.com/news/stocks/salix-pharma…
PAINWeek.... kann man so sagen.
https://markets.businessinsider.com/news/stocks/salix-pharma…
PAINWeek.... kann man so sagen.
Why Is Bausch (BHC) Down 10% Since Last Earnings Report?
https://finance.yahoo.com/news/why-bausch-bhc-down-10-142102… 11.04.24 · Accesswire · Bausch Health Companies |
11.04.24 · Accesswire · Bausch Health Companies |
03.04.24 · Accesswire · Bausch Health Companies |
02.04.24 · Accesswire · Bausch Health Companies |
06.03.24 · Accesswire · Bausch Health Companies |
05.03.24 · Accesswire · Bausch Health Companies |
04.03.24 · wO Chartvergleich · Myriad Genetics |
01.03.24 · Accesswire · Bausch Health Companies |
22.02.24 · wO Chartvergleich · Ameren |
22.02.24 · Accesswire · Bausch Health Companies |